Christine Mauz-Körholz Selected Research

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)

10/2018	18F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
9/2011	[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Mauz-Körholz Research Topics

Disease

18	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 08/2006
6	Neoplasms (Cancer) 02/2018 - 01/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 07/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 02/2018 - 11/2011
2	Lymphoma (Lymphomas) 02/2018 - 01/2014
2	Mycoses (Diseases, Fungus) 08/2010 - 04/2010
1	Leukemia 01/2014
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 04/2012
1	Osteopetrosis 04/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2011
1	Chromosome Breakage 11/2011
1	Ataxia (Dyssynergia) 11/2011
1	Nijmegen Breakage Syndrome 11/2011
1	Pathologic Complete Response 08/2010
1	Melanoma (Melanoma, Malignant) 07/2008
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2004
1	Neoplasm Metastasis (Metastasis) 01/2004

Drug/Important Bio-Agent (IBA)

5	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2004
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 08/2010
3	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 08/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2010
3	Procarbazine (Matulane)FDA Link 01/2022 - 08/2010
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018 - 09/2011
2	Dacarbazine (DIC)FDA LinkGeneric 05/2015 - 08/2010
2	Pharmaceutical PreparationsIBA 08/2006 - 01/2004
1	Circulating Tumor DNAIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Brentuximab VedotinIBA 02/2018
1	Rituximab (Mabthera)FDA Link 02/2018
1	Immunoconjugates (Immunoconjugate)IBA 02/2018
1	Immune Checkpoint InhibitorsIBA 02/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Complement Factor B (Factor B)IBA 01/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2014
1	Complementary DNA (cDNA)IBA 01/2014
1	Dual-Specificity PhosphatasesIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2013
1	defibrotideIBA 04/2012
1	Voriconazole (Vfend)FDA LinkGeneric 08/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2008
1	AntigensIBA 07/2008
1	Dihydrotachysterol (AT 10)IBA 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 08/2006
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2004
1	CaspasesIBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 10/2018 - 01/2004
6	Therapeutics 02/2018 - 01/2004
4	Radiotherapy 01/2022 - 01/2015
2	Aftercare (After-Treatment) 01/2022 - 09/2015
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2020
1	Consolidation Chemotherapy 01/2022
1	Salvage Therapy 01/2020
1	Immunotherapy 01/2019
1	Induction Chemotherapy 10/2018
1	Organ Transplantation 01/2017
1	Stem Cell Transplantation 04/2012